Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Wegovy

Ozempic and Wegovy maker courts prominent Black leaders to get Medicare's favor

Drugmaker Novo Nordisk focuses on Black lawmakers and opinion leaders to spread the message that obesity is a chronic disease — worth treating at a cost of $1,000 or more a month.

WEKU

Ozempic users report stomach paralysis as weight loss drug side effect: ‘I wish I never touched it’

The FDA has received reports of stomach paralysis among patients taking Ozempic and Wegovy

The Independent UK

Investors Seek Improved Weight-Loss Drugs With Focus On Nausea-Free Alternatives To Wegovy

Zenger

From analysis to the latest developments in health,
read the most diverse news in one place.

Nutritionist explains three foods that have the same effect as weight loss injections

Weight loss injections have been in the public eye in recent months

Wales Online

Nutritionist shares 3 foods that have 'same effect' as weight loss injection on body

Injections can have some unpleasant side effects

Nottingham Post

Nutritionist claims 3 foods have 'same effect' as weight loss injection

A nutritionist said regularly eating these foods can mimic effects of Wegovy and Ozempic

Liverpool Echo

Expert shares three foods that have 'similar effect' on body as weight loss injection

While weight loss injections are incredibly effective for shedding excess fat, they present some unpleasant side effects from time to time.

Chronicle Live

Read news from The Economist, FT, and more,
with one subscription

Nutritionist shares three foods that have 'same effect' as weight loss injection on body

While weight loss injections are effective for shedding pounds, they come with some unpleasant side effects.

Daily Record

Wegovy is "not a magic bullet" - 3 doctors reveal what you need to know as the drug is set to be prescribed in the UK

As Wegovy is set to be available on prescription in the UK, we asked doctors what they think of the controversial weight loss injections

Woman & Home

Side effects and 'damaging' health concerns of new NHS weight loss jab revealed

Medics have outlined the common side effects and potentially damaging health risks of the new weight loss drug, known as Wegovy, available to patients on the NHS

Daily Mirror

Why You Should Go Overweight On Novo Nordisk Stock

Novo Nordisk is already the global kingpin in diabetes treatments, with about 30% of the $50+ billion global diabetes market and around half of the $20 billion insulin therapy market. Now, it is becoming a powerhouse in weight-loss drugs, thanks to its Wegovy drug.

Barchart

Social Media adds to weight loss craze

GLP-1 agonists are a class of weight loss drug that is going viral on social media — but misinformation is rife

Salon

Novo Nordisk Sinks As Eli Lilly Plots Its Showdown In Obesity

Novo Nordisk stock dipped Monday after Eli Lilly posted the details of its study comparing Mounjaro and Wegovy in obesity treatment.

Investors Business Daily

Social media is fueling enthusiasm for new weight loss drugs. Are regulators watching?

Suzette Zuena is her own best advertisement for weight loss.

Tribune News Service

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Influencer calls out advertisements for weight-loss drugs in New York City subway stations: ‘Dystopian’

‘Not only do we advertise prescription drugs in the US, we paper the stairs of the train with them,’ influencer says

Marie Claire

So, is Wegovy the same as Ozempic? Your need-to-knows about the controversial over-the-counter weight loss drugs

Two experts explain.

The Guardian - UK

Revealed: maker of Wegovy ‘skinny jab’ is funding NHS weight-loss services

Critics fear conflict of interest as Novo Nordisk helps medics ‘reduce unnecessary barriers’ to treatment for obesity

The Guardian - UK

‘Skinny jab’ drug firm facing fresh inquiries after ‘serious breaches’ of industry code

Pharmaceutical company behind blockbuster diet jab Wegovy confronts crises on multiple fronts, amid scrutiny of UK activities

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

Firm behind Wegovy slimming jab suspended from UK trade association

Novo Nordisk found to be in breach of ABPI code of practice over sponsored weight-loss courses that promoted its medicines

The Guardian - UK

‘Orchestrated PR campaign’: how skinny jab drug firm sought to shape obesity debate

Maker of Wegovy, an appetite suppressor hailed as a weight-loss magic bullet, has spent millions on a slick PR campaign – including payments to some of its biggest cheerleaders

Daily Mirror

What is Wegovy and who is eligible as NHS approves weight loss drug

A weight loss jab have been approved for use through the NHS for people with at least one weight-related condition and a BMI score of at least 35

Investors Business Daily

AI Stock Headlines 5 Leaders Flashing Buy Signals As Market Rally Gains Steam

Arista Networks, which keeps popping up on lists of top AI stocks, leads this weekend's watch list of 5 stocks near buy points.

WEKU

Wegovy works. But here's what happens if you can't afford to keep taking the drug

The new weight-loss drugs can be life-changing for people facing health conditions worsened by obesity, but price and spotty insurance coverage may keep them out of reach.

ABC News

Semaglutide is causing a social media frenzy. So what is it?

It is not a a viral meme, but a drug that is an injectable medication — originally designed to treat diabetes — that has left those who need it waiting until next year for resupply.

Axios

The growing market for weight loss drugs

A new generation of FDA-approved diabetes drugs that can also help patients lose weight has prompted enthusiasm from doctors and a firestorm of demand among patients so strong it's led to shortages.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.